Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
James Sawalla Guseh, MD
Contributor
Dr. James Sawalla Guseh is director of the Cardiovascular Performance Program at Massachusetts General Hospital, and an assistant professor of medicine at Harvard Medical School. He trained at Harvard College and Harvard Medical School and completed his internal medicine residency at Mass General, where he also served as chief resident. His research focuses on human performance, aerobic fitness, and cardiovascular health; he is a recipient of the AHA Laennec Young Clinician Award, the Roman DeSanctis Clinical Scholar Award, and the Macomber Family Endowed Scholar in Cardiovascular Performance Innovation.
He is a primary author of the American Heart Association and American College of Cardiology Scientific Statement on sports participation in athletes with cardiovascular abnormalities, and served as a lead author on the task force addressing myocarditis, pericardial disease, and other acquired cardiovascular conditions.
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
